Search

everythinglearnresearchcommunity

for

Search:↓

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

Bee venom can help stem cells promote hair growth.

Hydrogels combined with extracellular vesicles and 3D bioprinting improve wound healing.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The author felt excited and honored to receive the 2016 Early Career Life Scientist Award.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Fusarium sp. strain K-23 helps Arabidopsis plants grow better in salty soil by promoting root hair growth.

Regenerative cosmetics can improve skin and hair by reducing wrinkles, healing wounds, and promoting hair growth.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

New hair loss treatment using marine collagen and dissolvable needles improves hair growth.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

New storage solutions improve the survival of small hair grafts and results of hair transplant surgeries.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Removing the outer layer of skin cells from hair grafts does not change the graft survival rate but may improve how it looks right after surgery.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

The sharp implanter method for hair graft placement is simpler and faster, allowing for dense packing of grafts with natural results.

More grafts and longer surgeries increase the risk of hair loss in the donor area after FUE hair transplants.

Bioactive peptides improve graft survival and new hair growth.

The new graft-holding solution is better at preserving hair grafts and reducing hair shedding after transplantation than the standard solution.

Plasma as a graft holding solution improves hair transplant results by increasing graft survival and promoting hair growth.

Transplanting beard hair into a scalp wound after hair transplant surgery improves scar appearance and hair keeps its normal traits.

Doctors should ensure grafts are well-prepared and correctly placed.